PIN60 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A VERSUS ENTECAVIR IN THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Abstract
Authors
F Sheng
F Sheng
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now